Rose Snyder
Hematology · Newark, NJNPI 1346772118
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.5% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,489 and has fallen 95.6% since, to $65 in 2025.
Across 94 payments — averaging $24.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$445
- Pfizer$217
- Takeda Pharmaceuticals U.S.A., Inc.$199
- Novartis$170
- Lilly USA, LLC$101
- Astellas Pharma US Inc$98
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,11794%
- Education$1476%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 16 | $445 |
| Pfizer | 12 | $217 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $199 |
| Novartis | 9 | $170 |
| Lilly USA, LLC | 5 | $101 |
| Astellas Pharma US Inc | 2 | $98 |
| Merck | 4 | $83 |
| Array Biopharma Inc | 3 | $70 |
| Genentech USA, Inc. | 2 | $67 |
| Seagen Inc. | 1 | $65 |
| Daiichi Sankyo Inc. | 2 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $54 |
| Myriad Genetic Laboratories, Inc. | 2 | $50 |
| Incyte Corporation | 2 | $47 |
| GSK | 2 | $41 |
| Gilead | 2 | $40 |
| Deciphera Pharmaceuticals Inc. | 1 | $33 |
| AVEO Pharmaceuticals, Inc. | 1 | $31 |
| CSL Behring | 1 | $31 |
| Sobi, Inc | 1 | $31 |
| Boston Scientific | 1 | $29 |
| Eisai Inc. | 1 | $28 |
| Menarini Silicon Biosystems, Inc. | 1 | $28 |
| Servier Pharmaceuticals LLC | 1 | $27 |
| Octapharma USA, Inc. | 1 | $27 |
| Bayer | 1 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $22 |
| Sanofi | 1 | $22 |
| Taiho Oncology, Inc. | 1 | $22 |
| Legend Biotech USA Inc. | 1 | $20 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TAGRISSO$119
How this compares
$2,264 in reported general payments places this provider in the 55th percentile of 43 hematology providers in New Jersey.
Other hematology in Newark
- Fermina MazzellaNewark$49K
- Marshall McKennaNewark$400
- Ahmed GalalMorristown$1.7M
- Mansi ShahNew Brunswick$131K
- Muhammad AbbasiMountain Lakes$22K
- Robert TassanWestwood$21K
- Marcus CarrNorth Brunswick$19K
- Jason LevitzMountain Lakes$19K
- Christopher TullyMountain Lakes$17K
- Claire PhilippNew Brunswick$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.